A Genome Scan Using a Novel Genetic Cross Identifies New Susceptibility Loci and Traits in a Mouse Model of Rheumatoid Arthritis

Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F(2) progeny. Using the F(2) hybrids resulting from an F(1) intercross of a newly identified suscepti...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of immunology (1950) Vol. 165; no. 9; pp. 5278 - 5286
Main Authors: Otto, Jeffrey M, Chandrasekeran, Raman, Vermes, Csaba, Mikecz, Katalin, Finnegan, Alison, Rickert, Sarah E, Enders, Jill T, Glant, Tibor T
Format: Journal Article
Language:English
Published: United States Am Assoc Immnol 01-11-2000
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F(2) progeny. Using the F(2) hybrids resulting from an F(1) intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F(2) hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN-gamma, IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs. IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2(b) and H-2(k)) of the C3H x C57BL/6 F(2) intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs.
AbstractList Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F(2) progeny. Using the F(2) hybrids resulting from an F(1) intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F(2) hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN-gamma, IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs. IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2(b) and H-2(k)) of the C3H x C57BL/6 F(2) intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs.
Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F2 progeny. Using the F2 hybrids resulting from an F1 intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F2 hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN-γ, IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2b and H-2k) of the C3H × C57BL/6 F2 intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs.
Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced in susceptible mouse strains and their F sub(2) progeny. Using the F sub(2) hybrids resulting from an F sub(1) intercross of a newly identified susceptible (C3H/HeJCr) and an established resistant (C57BL/6) strain of mouse, our goals were to: 1) identify the strain-specific loci that confer PGIA susceptibility, 2) determine whether any pathophysiological parameters could be used as markers that distinguish between nonarthritic and arthritic mice, and 3) analyze the effect of the MHC haplotype on quantitative trait loci (QTL) detection. To identify QTLs, we performed a genome scan on the F sub(2) hybrids. For pathophysiological analyses, we measured pro- and antiinflammatory cytokines such as IL-1, IL-6, IFN- gamma , IL-4, IL-10, IL-12, Ag-specific T cell proliferation and IL-2 production, serum IgG1 and IgG2 levels of both auto- and heteroantibodies, and soluble CD44. We have identified four new PGIA-linked QTLs (Pgia13 through Pgia16) and confirmed two (Pgia5, Pgia10) from our previous study. All new MHC-independent QTLs were associated with either disease onset or severity. Comprehensive statistical analysis demonstrated that while soluble CD44, IL-6, and IgG1 vs IgG2 heteroantibody levels differed significantly between the arthritic and nonarthritic groups, only Ab-related parameters colocalized with the QTLs. Importantly, the mixed haplotype (H-2 super(b) and H-2 super(k)) of the C3H x C57BL/6 F sub(2) intercross reduced the detection of several previously identified QTLs to suggestive levels, indicating a masking effect of unmatched MHCs.
Author Glant, Tibor T
Otto, Jeffrey M
Finnegan, Alison
Enders, Jill T
Vermes, Csaba
Mikecz, Katalin
Rickert, Sarah E
Chandrasekeran, Raman
Author_xml – sequence: 1
  fullname: Otto, Jeffrey M
– sequence: 2
  fullname: Chandrasekeran, Raman
– sequence: 3
  fullname: Vermes, Csaba
– sequence: 4
  fullname: Mikecz, Katalin
– sequence: 5
  fullname: Finnegan, Alison
– sequence: 6
  fullname: Rickert, Sarah E
– sequence: 7
  fullname: Enders, Jill T
– sequence: 8
  fullname: Glant, Tibor T
BackLink https://www.ncbi.nlm.nih.gov/pubmed/11046062$$D View this record in MEDLINE/PubMed
BookMark eNqFkUFv0zAUxy00xLrBJ0BCPsEpxXYcOz5W1RiTypBYOVtu8rK-KbFL7BDtxkfHVYvgxsWW_H7vr_f8uyIXPngg5C1nS8mk-fiEwzD50C-5qpZmWQldvyALXlWsUIqpC7JgTIiCa6UvyVWMT4wxxYR8RS45ZzIjYkF-regt-DAAfWicp98j-kfq6H34Cf2xAgkbuh5DjPSuBZ-wQ4j0Hmb6MMUGDgl32GN6ppvQIHW-pdvRYYoUfY75EqYI-WxzWOjotz1Mg0sBW7oa037EhPE1edm5PsKb831Ntp9utuvPxebr7d16tSkayUwqjNPGCCFbJ2Qla5236jRUOm9rSl11XAlW11plrOSm5lru8mPHROO04qa8Ju9PsYcx_JggJjtgnr_vnYc8pNWiVMJI8V-Qay2YEVUGyxPYHH9nhM4eRhzc-Gw5s0dB9o8gmwVZY4-Ccte7c_y0G6D923M2koEPJ2CPj_sZR7BxcH2fcW7nef4n6jd9HpwT
CitedBy_id crossref_primary_10_4049_jimmunol_181_2_1307
crossref_primary_10_1186_ar624
crossref_primary_10_1038_gene_2012_2
crossref_primary_10_1002_art_11275
crossref_primary_10_4049_jimmunol_175_4_2475
crossref_primary_10_1038_gene_2008_54
crossref_primary_10_1002_art_20366
crossref_primary_10_1002_art_20786
crossref_primary_10_1016_j_mce_2009_07_017
crossref_primary_10_1046_j_1365_3083_2003_01235_x
crossref_primary_10_1002_art_20624
crossref_primary_10_1097_00002281_200109000_00003
crossref_primary_10_4049_jimmunol_168_12_6013
crossref_primary_10_1002_1529_0131_200103_44_3_682__AID_ANR118_3_0_CO_2_E
crossref_primary_10_1046_j_1365_2249_2002_01903_x
crossref_primary_10_4049_jimmunol_170_5_2283
crossref_primary_10_4049_jimmunol_172_11_6723
crossref_primary_10_1002_art_20285
crossref_primary_10_1016_S0002_9440_10_63018_0
crossref_primary_10_1002_art_11016
crossref_primary_10_4049_jimmunol_174_1_435
crossref_primary_10_4049_jimmunol_170_2_1019
crossref_primary_10_4049_jimmunol_166_5_2944
crossref_primary_10_1002_art_20655
crossref_primary_10_1016_S0168_9525_02_02684_7
crossref_primary_10_1097_00000441_200404000_00004
crossref_primary_10_1111_j_0906_6705_2005_00348_x
crossref_primary_10_1016_S0888_7543_03_00208_8
crossref_primary_10_1017_S0016672310000704
crossref_primary_10_1038_sj_gene_6364419
crossref_primary_10_1155_2012_284751
crossref_primary_10_1002_art_10555
crossref_primary_10_4049_jimmunol_174_12_7894
crossref_primary_10_1007_s10753_006_8962_6
Cites_doi 10.1172/JCI1817
10.1016/S0092-8674(00)81110-1
10.1046/j.1365-2249.2000.01174.x
10.1136/jmg.33.8.672
10.1038/ng0795-313
10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M
10.1002/(SICI)1096-8628(19990507)84:1<15::AID-AJMG4>3.0.CO;2-O
10.1002/jbmr.5650080907
10.4049/jimmunol.162.5.2581
10.1016/S0198-8859(99)00048-8
10.4049/jimmunol.163.5.2916
10.4049/jimmunol.162.4.1917
10.1093/hmg/6.9.1401
10.1073/pnas.95.18.10746
10.1002/art.1780300310
10.1086/302061
10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6
10.4049/jimmunol.162.4.2415
10.1086/302767
10.1016/S0952-7915(99)00038-2
10.1038/ng0695-240
10.1006/cimm.1994.1277
10.1093/genetics/139.3.1421
10.1002/art.1780330614
10.1096/fasebj.6.11.1644260
10.2337/diabetes.47.9.1525
10.4049/jimmunol.163.10.5383
10.1073/pnas.95.25.14875
10.4049/jimmunol.160.8.3812
10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0
10.1038/3887
10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0
10.1016/0008-8749(92)90250-S
10.2337/diabetes.48.5.1175
10.4049/jimmunol.162.2.948
10.1002/1529-0131(199812)41:12<2122::AID-ART7>3.0.CO;2-#
10.1016/S0041-1345(99)00047-0
10.1073/pnas.95.25.14869
10.1093/hmg/5.Supplement_1.1443
10.1016/S0952-7915(98)80090-3
10.1006/geno.1996.0153
10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z
10.1016/S0041-1345(99)00052-4
10.1038/ng0996-82
10.1073/pnas.96.5.2210
10.1002/art.1780300211
10.1038/ng0996-90
10.4049/jimmunol.161.8.4411
10.1007/s004390050245
10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E
10.1172/JCI118648
10.1038/ng1195-241
10.1073/pnas.95.17.9979
10.1016/0888-7543(87)90010-3
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
8FD
FR3
H94
P64
RC3
7X8
DOI 10.4049/jimmunol.165.9.5278
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Genetics Abstracts
Immunology Abstracts
Engineering Research Database
Technology Research Database
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Biology
EISSN 1550-6606
EndPage 5286
ExternalDocumentID 10_4049_jimmunol_165_9_5278
11046062
www165_9_5278
Genre Research Support, U.S. Gov't, P.H.S
Comparative Study
Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: AR-40310
– fundername: NIAMS NIH HHS
  grantid: AR-45652
GroupedDBID -
08R
2WC
34G
39C
3O-
53G
55
5GY
5RE
5VS
79B
85S
8RP
AALRV
AARDX
ABEFU
ABFLS
ABOCM
ABPPZ
ABPTK
ACGFS
ACIWK
ACNCT
ACPRK
ADACO
ADBBV
ADKFC
AENEX
AETEA
AFFNX
AFRAH
AJYGW
ALMA_UNASSIGNED_HOLDINGS
BAWUL
D0L
DIK
DU5
E3Z
EBS
EJD
F5P
FH7
FRP
G8K
GJ
GX1
IH2
J5H
K-O
K78
KQ8
L7B
MVM
MYA
NEJ
O0-
OK1
P0W
P2P
PQEST
PQQKQ
R.V
RHF
RHI
RZQ
SJN
TWZ
VH1
WH7
WOQ
X
X7M
XFK
XJT
YCJ
ZA5
ZE2
ZGI
ZXP
---
-~X
.55
.GJ
18M
ABCQX
ABJNI
ACGFO
ADNWM
AFHIN
AFOSN
AHWXS
AI.
AIZAD
BTFSW
CGR
CUY
CVF
ECM
EIF
NPM
TR2
W8F
XSW
XTH
YHG
AAYXX
ABDPE
CITATION
7T5
8FD
FR3
H94
P64
RC3
7X8
ID FETCH-LOGICAL-c409t-9a799224da245487176f7e575509375f16208876a793198174b5f1f02ca76193
ISSN 0022-1767
IngestDate Fri Oct 25 05:47:46 EDT 2024
Fri Oct 25 02:04:09 EDT 2024
Thu Nov 21 23:41:59 EST 2024
Sat Sep 28 08:38:40 EDT 2024
Tue Nov 10 19:50:43 EST 2020
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 9
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c409t-9a799224da245487176f7e575509375f16208876a793198174b5f1f02ca76193
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://journals.aai.org/jimmunol/article-pdf/165/9/5278/1124010/5278.pdf
PMID 11046062
PQID 17720925
PQPubID 23462
PageCount 9
ParticipantIDs proquest_miscellaneous_72362942
proquest_miscellaneous_17720925
crossref_primary_10_4049_jimmunol_165_9_5278
pubmed_primary_11046062
highwire_smallpub1_www165_9_5278
ProviderPackageCode RHF
RHI
PublicationCentury 2000
PublicationDate 20001101
2000-Nov-01
2000-11-01
PublicationDateYYYYMMDD 2000-11-01
PublicationDate_xml – month: 11
  year: 2000
  text: 20001101
  day: 01
PublicationDecade 2000
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle The Journal of immunology (1950)
PublicationTitleAlternate J Immunol
PublicationYear 2000
Publisher Am Assoc Immnol
Publisher_xml – name: Am Assoc Immnol
References 2023010117570289700_R41
2023010117570289700_R40
2023010117570289700_R43
2023010117570289700_R42
2023010117570289700_R45
2023010117570289700_R44
2023010117570289700_R36
2023010117570289700_R35
2023010117570289700_R38
2023010117570289700_R37
2023010117570289700_R39
2023010117570289700_R1
2023010117570289700_R30
2023010117570289700_R4
2023010117570289700_R32
2023010117570289700_R5
2023010117570289700_R31
2023010117570289700_R2
2023010117570289700_R34
2023010117570289700_R3
2023010117570289700_R33
2023010117570289700_R8
2023010117570289700_R9
2023010117570289700_R6
2023010117570289700_R7
2023010117570289700_R25
2023010117570289700_R24
2023010117570289700_R27
2023010117570289700_R26
2023010117570289700_R29
2023010117570289700_R28
2023010117570289700_R61
2023010117570289700_R60
2023010117570289700_R63
2023010117570289700_R62
2023010117570289700_R21
2023010117570289700_R65
2023010117570289700_R20
2023010117570289700_R64
2023010117570289700_R23
2023010117570289700_R22
2023010117570289700_R14
2023010117570289700_R58
2023010117570289700_R13
2023010117570289700_R57
2023010117570289700_R16
2023010117570289700_R15
2023010117570289700_R59
2023010117570289700_R18
2023010117570289700_R17
2023010117570289700_R19
2023010117570289700_R50
2023010117570289700_R52
2023010117570289700_R51
2023010117570289700_R10
2023010117570289700_R54
2023010117570289700_R53
2023010117570289700_R12
2023010117570289700_R56
2023010117570289700_R11
2023010117570289700_R55
2023010117570289700_R47
2023010117570289700_R46
2023010117570289700_R49
2023010117570289700_R48
References_xml – ident: 2023010117570289700_R26
  doi: 10.1172/JCI1817
– ident: 2023010117570289700_R16
  doi: 10.1016/S0092-8674(00)81110-1
– ident: 2023010117570289700_R49
  doi: 10.1046/j.1365-2249.2000.01174.x
– ident: 2023010117570289700_R25
  doi: 10.1136/jmg.33.8.672
– ident: 2023010117570289700_R28
  doi: 10.1038/ng0795-313
– ident: 2023010117570289700_R12
  doi: 10.1002/(SICI)1521-4141(199810)28:10<3321::AID-IMMU3321>3.0.CO;2-M
– ident: 2023010117570289700_R40
  doi: 10.1002/(SICI)1096-8628(19990507)84:1<15::AID-AJMG4>3.0.CO;2-O
– ident: 2023010117570289700_R51
  doi: 10.1002/jbmr.5650080907
– ident: 2023010117570289700_R24
  doi: 10.4049/jimmunol.162.5.2581
– ident: 2023010117570289700_R41
  doi: 10.1016/S0198-8859(99)00048-8
– ident: 2023010117570289700_R14
  doi: 10.4049/jimmunol.163.5.2916
– ident: 2023010117570289700_R27
  doi: 10.4049/jimmunol.162.4.1917
– ident: 2023010117570289700_R36
  doi: 10.1093/hmg/6.9.1401
– ident: 2023010117570289700_R4
  doi: 10.1073/pnas.95.18.10746
– ident: 2023010117570289700_R21
  doi: 10.1002/art.1780300310
– ident: 2023010117570289700_R37
  doi: 10.1086/302061
– ident: 2023010117570289700_R23
  doi: 10.1002/1529-0131(199806)41:6<1007::AID-ART7>3.0.CO;2-6
– ident: 2023010117570289700_R47
  doi: 10.4049/jimmunol.162.4.2415
– ident: 2023010117570289700_R43
  doi: 10.1086/302767
– ident: 2023010117570289700_R19
  doi: 10.1016/S0952-7915(99)00038-2
– ident: 2023010117570289700_R30
  doi: 10.1038/ng0695-240
– ident: 2023010117570289700_R55
– ident: 2023010117570289700_R50
  doi: 10.1006/cimm.1994.1277
– ident: 2023010117570289700_R59
– ident: 2023010117570289700_R1
– ident: 2023010117570289700_R54
  doi: 10.1093/genetics/139.3.1421
– ident: 2023010117570289700_R58
  doi: 10.1002/art.1780330614
– ident: 2023010117570289700_R5
– ident: 2023010117570289700_R63
  doi: 10.1096/fasebj.6.11.1644260
– ident: 2023010117570289700_R38
  doi: 10.2337/diabetes.47.9.1525
– ident: 2023010117570289700_R48
  doi: 10.4049/jimmunol.163.10.5383
– ident: 2023010117570289700_R45
  doi: 10.1073/pnas.95.25.14875
– ident: 2023010117570289700_R22
  doi: 10.4049/jimmunol.160.8.3812
– ident: 2023010117570289700_R15
  doi: 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0
– ident: 2023010117570289700_R9
  doi: 10.1038/3887
– ident: 2023010117570289700_R6
  doi: 10.1002/1529-0131(199804)41:4<588::AID-ART5>3.0.CO;2-0
– ident: 2023010117570289700_R56
– ident: 2023010117570289700_R62
  doi: 10.1016/0008-8749(92)90250-S
– ident: 2023010117570289700_R39
  doi: 10.2337/diabetes.48.5.1175
– ident: 2023010117570289700_R64
  doi: 10.4049/jimmunol.162.2.948
– ident: 2023010117570289700_R11
  doi: 10.1002/1529-0131(199812)41:12<2122::AID-ART7>3.0.CO;2-#
– ident: 2023010117570289700_R2
– ident: 2023010117570289700_R17
  doi: 10.1016/S0041-1345(99)00047-0
– ident: 2023010117570289700_R61
– ident: 2023010117570289700_R29
  doi: 10.1002/1529-0131(199912)42:12<2524::AID-ANR4>3.0.CO;2-0
– ident: 2023010117570289700_R44
  doi: 10.1073/pnas.95.25.14869
– ident: 2023010117570289700_R35
  doi: 10.1093/hmg/5.Supplement_1.1443
– ident: 2023010117570289700_R46
  doi: 10.1016/S0952-7915(98)80090-3
– ident: 2023010117570289700_R32
– ident: 2023010117570289700_R34
  doi: 10.1006/geno.1996.0153
– ident: 2023010117570289700_R52
  doi: 10.1002/1529-0131(199904)42:4<659::AID-ANR8>3.0.CO;2-Z
– ident: 2023010117570289700_R8
  doi: 10.1016/S0041-1345(99)00052-4
– ident: 2023010117570289700_R10
  doi: 10.1038/ng0996-82
– ident: 2023010117570289700_R13
  doi: 10.1073/pnas.96.5.2210
– ident: 2023010117570289700_R20
  doi: 10.1002/art.1780300211
– ident: 2023010117570289700_R33
  doi: 10.1038/ng0996-90
– ident: 2023010117570289700_R7
  doi: 10.4049/jimmunol.161.8.4411
– ident: 2023010117570289700_R42
  doi: 10.1007/s004390050245
– ident: 2023010117570289700_R3
– ident: 2023010117570289700_R65
  doi: 10.1002/1529-0131(200103)44:3<682::AID-ANR118>3.0.CO;2-E
– ident: 2023010117570289700_R60
– ident: 2023010117570289700_R31
  doi: 10.1172/JCI118648
– ident: 2023010117570289700_R57
  doi: 10.1038/ng1195-241
– ident: 2023010117570289700_R18
  doi: 10.1073/pnas.95.17.9979
– ident: 2023010117570289700_R53
  doi: 10.1016/0888-7543(87)90010-3
SSID ssj0006024
Score 1.8946828
Snippet Proteoglycan-induced arthritis (PGIA) is a murine model for rheumatoid arthritis (RA) both in terms of its pathology and its genetics. PGIA can only be induced...
SourceID proquest
crossref
pubmed
highwire
SourceType Aggregation Database
Index Database
Publisher
StartPage 5278
SubjectTerms Animals
Arthritis, Rheumatoid - genetics
Arthritis, Rheumatoid - immunology
Arthritis, Rheumatoid - physiopathology
Crosses, Genetic
Disease Models, Animal
Female
Genetic Markers - genetics
Genetic Markers - immunology
Genetic Predisposition to Disease - genetics
Genome
Injections, Intraperitoneal
Male
Mice
Mice, Inbred BALB C
Mice, Inbred C3H
Mice, Inbred C57BL
Polymorphism, Genetic - immunology
Proteoglycans - administration & dosage
Proteoglycans - immunology
Quantitative Trait, Heritable
Species Specificity
Statistics, Nonparametric
Title A Genome Scan Using a Novel Genetic Cross Identifies New Susceptibility Loci and Traits in a Mouse Model of Rheumatoid Arthritis
URI http://www.jimmunol.org/cgi/content/abstract/165/9/5278
https://www.ncbi.nlm.nih.gov/pubmed/11046062
https://search.proquest.com/docview/17720925
https://search.proquest.com/docview/72362942
Volume 165
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6lRSAuCMor5TUHOJmkzsbPYwSpKtSGQw3qbbW216rV1EZx3Kic-OnM7Nqxi6iAA5coWttrx9-Xee3sDGNvpyjvEh4ko4zTMmOS2KMglJTv4Htx6vuuVBTTPTr1F2fBx7kzHwzaXoDd2H9FGscQa9o5-w9obyfFAfyOmOMnoo6ff4X7jJoil5fKqki-1ToUIK2ivFJLOkJ7Fi2tGq08NZlCqqK-4lZVVzrFRWfLXluo5HKTXrmStLiQFzgNxQmU6Z5DVubqXNVo8ZZ5SrWSznV9pL612-07M6UpaC-Kqfn0Tq-s2f0o73ptFoGsfspBka5QzV6oVbNc1R76igrFCLhtlPckv1DJ9y5y24Yy7GZPX088o2c88U1_jq14Nr0kGh6GPWHrctP9p1HcLjdFtX9VCg46QaQUmh85xgnH4bi7uF-Ce_FZHH45PhbR_CzaYXc4Si9qyHD6abFV757NnbYEPT2rKWVFNzn4zS1umjttCerb3Rlt1kQP2YMGHZgZIj1iA1XssbumQ-n1Hrt30uRePGY_ZmCYBcQs0MwCCZpZ0DAL9FNAxyxAZsFNZgExCxBZMMyCvMBpNLNAMwvKDDpmwZZZT1h0OI8-HI2a_h2jxLHD9SiUPlU9dlLJHXKM8W1lvkL_AI3Uqe9mE4-TjvPwNFQEAfrGMQ5mNk8kBdemT9luURbqOQO0YxMlMzdW8dSJpYxxwgx9bztQAZrs2ZC9b9-y-GaqtAj0bgkU0YIiEBQRCgJlyKBFQlSXcrlEBCZis9n0T3nTIiRQ4NIqmiwUvgoxQX_UDrl7-xk-R6swdPiQPTPQds9EGRW2x_f_eO0Ldr_7h7xku-tVrV6xnSqtX2s6_gSz2rPA
link.rule.ids 315,782,786,27934,27935
linkProvider Multiple Vendors
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+genome+scan+using+a+novel+genetic+cross+identifies+new+susceptibility+loci+and+traits+in+a+mouse+model+of+rheumatoid+arthritis&rft.jtitle=The+Journal+of+immunology+%281950%29&rft.au=Otto%2C+J+M&rft.au=Chandrasekeran%2C+R&rft.au=Vermes%2C+C&rft.au=Mikecz%2C+K&rft.date=2000-11-01&rft.issn=0022-1767&rft.volume=165&rft.issue=9&rft.spage=5278&rft.epage=5286&rft_id=info:doi/10.4049%2Fjimmunol.165.9.5278&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-1767&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-1767&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-1767&client=summon